Ultrasound-guided percutaneous portal transplantation of peripheral blood monocytes in patients with liver cirrhosis

作者：Yu Su Jong; Yoon Jung Hwan^*; Kim Won; Lee Jeong Min; Bin Lee Yun; Cho Yuri; Lee Dong Hyeon; Lee Minjong; Yoo Jeong Ju; Cho Eun Ju; Lee Jeong Hoon; Kim Yoon Jun; Kim Chung Yong

来源：Korean Journal of Internal Medicine, 2017, 32(2): 261-268.

DOI：10.3904/kjim.2015.267

• Leukocytes
• mononuclear
• Granulocyte colony-stimulating factor
• Liver cirrhosis

Background/Aims: Liver transplantation offers the only definite cure for cirrhosis but lacking donors is problem. Stem cell therapy is attractive in this setting. In this study, we aimed to explore the safety and efficacy of ultrasound-guided percutaneous portal transplantation of peripheral blood monocyte cell (PBMC) in cirrhotic patients.
Methods: A total of nine decompensated cirrhotic patients were randomized into three groups: group 1 (n = 3) was control group, group 2 (n = 3) received granulo-cyte- colony stimulating factor (G-CSF) mobilization for 3 days, and group 3 (n = 3) received G-CSF mobilized PBMCs by leukapheresis and PBMC transplantation through ultrasound-guided percutaneous portal vein puncture. Liver function and clinical features were evaluated.
Results: At baseline, the Child-Turcotte-Pugh and the model for end-stage liver disease scores were comparable in study groups. Compared with group 1, there was a tendency to improve liver function in group 3 at 6 months after treatment. Treatment was tolerable and no complications were encountered related to the G-CSF mobilization or percutaneous portal administration of PBMCs. Imaging studies showed patent portal veins at the end of the study period.
Conclusions: Autologous PBMC transplantation through ultrasound-guided percutaneous portal vein puncture could be considered as a safe alternative treatment for decompensated cirrhotic patients.

• 出版日期2017-3